Arcus Biosciences, Inc. (RCUS): Weighted Average Diluted Shares
107.40M
Year ended 2025-12-31
+14.3%
3-year compound annual growth
+14.4%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 107.40M | +19.2% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | 90.10M | +21.8% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | 74.00M | +2.8% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | 72.00M | -2.7% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | 74.00M | +35.0% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | 54.80M | +25.0% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | 43.83M | n/a | 2022-02-23, From 2019-01-01 |